FDA Approved: JELMYTO — Supplemental Application (UroGen Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Jelmyto (mitomycin) submitted by UroGen Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• JELMYTO (MITOMYCIN)

Snippet

SUPPL AP for JELMYTO (MITOMYCIN)